NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases

British Journal of Haematology

Volumn 107, Issue 3, 1999, Pages 674-676

  Mauvieux, L ^a,b   Delabesse, E ^a,b   Bourquelot, P ^a,b   Radford Weiss, I ^a,b   Bennaceur, A L ^a,b   Flandrin, G ^a,b   Valensi, F ^a,b   Macintyre, E A ^a,b,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Laboratoire Central d'Hematologie   (France)

Author keywords

AML; MLL; Monocytic immunophenotype; NG2

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CELL MATURATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; INFANT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0032755047     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01730.x     Document Type: Article

References (11)

1. Behm, F.G., Raimondi, S.C., Frestedt, J.L., Liu, Q., Crist, W.M., Downing, J.R., Rivera, G.K., Kersey, J.H. & Pui, C.H. (1996a) Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood, 87, 2870-2877.
2. Behm, F.G., Smith, F.O., Raimondi, S.C., Pui, C.H. & Bernstein, I.D. (1996b) Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identities childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements. Blood, 87, 1134-1139.
3. Harrison, C.J., Cuneo, A., Clark, R., Johansson, B., Lafage-Pochitaloff, M., Mugneret, E, Moorman, A.V. & Secker-Walker, L.M. (1998) Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants. Leukemia, 12, 811-822.
4. Hilden, J.M., Smith, F.O., Frestedt, J.L., McGlennen, R., Howells, W.B., Sorensen, P.H., Arthur, D.C., Woods, W.G., Buckley, J., Bernstein, I.D. & Kersey. J.H. (1997) MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia. Blood, 89, 3801-3805.
5. Levine, J.M. & Nishiyama, A. (1996) The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells. Perspectives in Developmental Neurobiology, 3, 245-259.
6. Martinez-Climent, J.A., Espinosa, R., Thirman, M.J., LeBeau, M.M. & Rowley, J.D. (1995) Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias: identification of the t(9;11) as an indicator of long survival. Journal of Pediatric Hematology and Oncology, 17, 277-283.
7. Poirel, H., Rack, K., Delabesse, E., Radford-Weiss, I., Troussard, X., Debert, C., Leboeuf, D., Bastard, C., Picard, F., Veil-Buzyn, A., Flandrin, G., Bernard, O. & Macintyre, E. (1996) Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5. Blood, 87, 2496-2505.
8. Rubnitz, J.E., Behm, F.G. & Downing, J.R. (1996) 11q23 rearrangements in acute leukemia. Leukemia, 10, 74-82.
9. Smith, F.O., Rauch, C., Williams, D.E., March, C.J., Arthur, D., Hilden, J., Lampkin, B.C., Buckley, J.D., Buckley, C.V., Woods, W.G., Dinndorf, P.A., Sorensen, P., Kersey, J., Hammond, D. & Bernstein, I.D. (1996) The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23. Blood, 87, 1123-1133.
10. Taki, T., Ida, K., Bessho, F., Hanada, R., Kikuchi, A., Yamamoto, K., Sako, M., Tsuchida, M., Seto, M., Ueda, R. & Hayashi, Y. (1996) Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia, Leukemia, 10, 1303-1307.
11. Yu, M., Honoki, K., Andersen, J., Paietta, E., Nam, D.K. & Yunis, J.J. (1996) MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia, 10, 774-780.